4HJO
Crystal structure of the inactive EGFR tyrosine kinase domain with erlotinib
Summary for 4HJO
Entry DOI | 10.2210/pdb4hjo/pdb |
Descriptor | Epidermal growth factor receptor, [6,7-BIS(2-METHOXY-ETHOXY)QUINAZOLINE-4-YL]-(3-ETHYNYLPHENYL)AMINE (3 entities in total) |
Functional Keywords | inactive tyrosine kinase domain, transferase-transferase inhibitor complex, transferase/transferase inhibitor |
Biological source | Homo sapiens (human) |
Cellular location | Cell membrane; Single-pass type I membrane protein. Isoform 2: Secreted: P00533 |
Total number of polymer chains | 1 |
Total formula weight | 38950.01 |
Authors | Park, J.H.,Lemmon, M.A. (deposition date: 2012-10-13, release date: 2012-11-14, Last modification date: 2023-09-20) |
Primary citation | Park, J.H.,Liu, Y.,Lemmon, M.A.,Radhakrishnan, R. Erlotinib binds both inactive and active conformations of the EGFR tyrosine kinase domain. Biochem.J., 448:417-423, 2012 Cited by PubMed: 23101586DOI: 10.1042/BJ20121513 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.75 Å) |
Structure validation
Download full validation report